Panmure Gordon was delighted to act as a Rule 3 Adviser, Joint Financial Adviser and Joint Broker to CareTech Holdings plc for the recommended cash offer to acquire CareTech for c. £870m with their official delisting from the London Stock Exchange. Panmure Gordon’s team included: Emma Earl, Freddy…
Read more
Panmure Gordon is delighted to announce that it has been appointed as Joint Broker to EQTEC plc. EQTEC designs, supplies and builds advanced gasification facilities in the UK, EU and US, which process over 50 varieties of feedstock, including forestry wood waste, vegetation and other agricultural to…
Read more
Panmure Gordon is deeply saddened by the death of Her Majesty Queen Elizabeth II and our thoughts and sympathies are with The Royal Family at this difficult time. We will remember with deep gratitude her incredible dedication and tireless work for the people of the United Kingdom and…
Read more
Panmure Gordon is delighted to announce that is acted as sole bookrunner, broker and nominated adviser for the £5.7m placing for C4X Discovery Holdings plc. C4XD is a Drug Discovery company combining scientific expertise with Drug Discovery technologies to efficiently deliver medicines, which are developed by partners for the…
Read more
We have today announced our appointment as Joint Broker to European Metals Holdings (EMH). EMH is a mineral exploration and development company with a focus on creating a sustainable lithium supply chain with a low carbon footprint servicing the European markets. The Company are currently advancing the…
Read more
We have today announced our appointment as Sole Financial Adviser and Corporate Broker to Carclo plc. Carclo plc is a UK-based global manufacturer, principally of fine tolerance injection moulded plastic parts for the medical, diagnostics, electronics, optics and automotive safety markets. The Company operates through two core divisions:…
Read more
We have today announced our appointment as Joint Broker to Zephyr Energy PLC (ZPHR). Market cap £83m, listed on AIM. Zephyr Energy is an investment platform formed to aggregate oil and gas interests in the Rocky Mountain region of the United States. The company’s continued focus is to…
Read more
Panmure Gordon is delighted to have acted as sole Bookrunner, Broker and Nominated Adviser to Arecor Therapeutics on their recent placing to raise £6.0 million and acquisition of Tetris Pharma, a commercial stage speciality pharmaceutical company. The proceeds of the Placing will be used to support the acquisition…
Read more
We are delighted to have acted as corporate adviser, sole broker and sole bookrunner with the £10m IPO and introduction to AQSE of Equipmake Holdings PLC. Read the full press release below. Equipmake Holdings PLC (“Equipmake” or the “Company“) Admission to trading on AQSE and…
Read more
We are delighted to announce that our Healthcare Research Analyst, Dr. Julie Simmonds, has been crowned ‘Analyst of the Year 2022’ by the Small Cap Network Awards. Thank you to all the judges who voted. Find out more about the Small Cap Network Awards here: https://smallcapnetwork.co.uk/…
Read more
We are pleased to announced that Panmure Gordon has this morning been appointed as Financial Adviser, Nominated Adviser and sole Broker to GetBusy Plc. GetBusy is listed on AIM with a £29m market cap. GetBusy is a Cambridge-based SaaS business, which is primarily engaged in the development…
Read more
We are delighted to announce that Panmure Gordon has been appointed as Nominated Adviser and Sole Broker to Smoove PLC. Smoove plc is the customer focused technology and services business aiming to revolutionise home moving and ownership. Congratulations to all those involved, especially our Panmure Gordon colleagues:…
Read more